Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.12.7439

ATF3 Activates Stat3 Phosphorylation through Inhibition of p53 Expression in Skin Cancer Cells  

Hao, Zhen-Feng (Graduate Management Brigade, Third Military Medical University)
Ao, Jun-Hong (Institute of Skin Damage and Repair, General Hospital of Beijing Region of PLA)
Zhang, Jie (Institute of Skin Damage and Repair, General Hospital of Beijing Region of PLA)
Su, You-Ming (Institute of Skin Damage and Repair, General Hospital of Beijing Region of PLA)
Yang, Rong-Ya (Institute of Skin Damage and Repair, General Hospital of Beijing Region of PLA)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.12, 2013 , pp. 7439-7444 More about this Journal
Abstract
Aim: ATF3, a member of the ATF/CREB family of transcription factors, has been found to be selectively induced by calcineurin/NFAT inhibition and to enhance keratinocyte tumor formation, although the precise role of ATF3 in human skin cancer and possible mechanisms remain unknown. Methods: In this study, clinical analysis of 30 skin cancer patients and 30 normal donors revealed that ATF3 was accumulated in skin cancer tissues. Functional assays demonstrated that ATF3 significantly promoted skin cancer cell proliferation. Results: Mechanically, ATF3 activated Stat3 phosphorylation in skin cancer cell through regulation of p53 expression. Moreover, the promotion effect of ATF3 on skin cancer cell proliferation was dependent on the p53-Stat3 signaling cascade. Conclusion: Together, the results indicate that ATF3 might promote skin cancer cell proliferation and enhance skin keratinocyte tumor development through inhibiting p53 expression and then activating Stat3 phosphorylation.
Keywords
ATF3; Stat3 phosphorylation; p53 expression; skin cancer cell;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Allan AL, Albanese C, Pestell RG, LaMarre J (2001). Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J Biol Chem, 276, 27272-80.   DOI   ScienceOn
2 Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T (2001). The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem, 276, 29507-14.   DOI   ScienceOn
3 Boni R, Schuster C, Nehrhoff B, Burg G (2002). Epidemiology of skin cancer. Neuro Endocrinol Lett, 23, 48-51.
4 Cai Y, Zhang C, Nawa T, et al (2000). Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2).-terminal kinase and promoter response element. Blood, 96, 2140-8.
5 Chen BP, Wolfgang CD, Hai T (1996). Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol, 16, 1157-68.   DOI
6 Corvinus FM, Orth C, Moriggl R, et al (2005). Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia, 7, 545-55.   DOI
7 Diepgen TL, Mahler V (2002). The epidemiology of skin cancer. Br J Dermatol, 146, 1-6.
8 Fan F, Jin S, Amundson SA, et al (2002). ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene, 21, 7488-96.   DOI   ScienceOn
9 Gold ES, Ramsey SA, Sartain MJ, et al (2012). ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med, 209, 807-17.   DOI   ScienceOn
10 Gordon R (2013). Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs, 29, 160-9.   DOI   ScienceOn
11 Hai T, Hartman MG (2001). The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene, 273, 1-11.   DOI   ScienceOn
12 Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U (1999). ATF3 and stress responses. Gene Expr, 7, 321-35.
13 Hodge DR, Hurt EM, Farrar WL (2005). The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer, 41, 2502-12.   DOI   ScienceOn
14 Huang X, Li X, Guo B (2008). KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J Biol Chem, 283, 29795-801.   DOI   ScienceOn
15 Ishiguro T, Nagawa H (2000). Expression of the ATF3 gene on cell lines and surgically excised specimens. Oncol Res, 12, 181-3.
16 Ishiguro T, Nagawa H, Naito M, Tsuruo T (2000). Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells. Jpn J Cancer Res, 91, 833-6.   DOI
17 Jang MK, Kim CH, Seong JK, Jung MH (2012). ATF3 inhibits adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun, 421, 38-43.   DOI   ScienceOn
18 Kamran MZ, Patil P, Gude RP (2013). Role of STAT3 in Cancer Metastasis and Translational Advances. Biomed Res Int, 2013, 421821.
19 Koike M, Ninomiya Y, Koike A (2005). Characterization of ATF3 induction after ionizing radiation in human skin cells. J Radiat Res, 46, 379-85.   DOI   ScienceOn
20 Kiryu-Seo S, Kato R, Ogawa T, Nakagomi S, Nagata K, Kiyama H (2008). Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons. J Biol Chem, 283, 6988-96.   DOI   ScienceOn
21 Kool J, Hamdi M, Cornelissen-Steijger P, van der Eb AJ, Terleth C, van Dam H (2003). Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene, 22, 4235-42.   DOI   ScienceOn
22 Lee SH, Min KW, Zhang X, Baek SJ (2013). 3,3'-diindolylmethane induces activating transcription factor 3 (ATF3). via ATF4 in human colorectal cancer cells. J Nutr Biochem, 24, 664-71.   DOI   ScienceOn
23 Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T (1996). ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem, 271, 1695-701.   DOI
24 Lin J, Tang H, Jin X, Jia G, Hsieh JT (2002). p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3. Oncogene, 21, 3082-8.   DOI
25 Niu G, Wright KL, Ma Y et al. (2005). Role of Stat3 in regulating p53 expression and function. Mol Cell Biol, 25, 7432-40.   DOI   ScienceOn
26 Perez S, Vial E, van Dam H, Castellazzi M (2001). Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation. Oncogene, 20, 1135-41.   DOI
27 Thompson MR, Xu D, Williams BR (2009). ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med, 87, 1053-60.   DOI   ScienceOn
28 Rose CL, Chakravarti N, Curry JL (2012). The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol, 39, 762-8.   DOI   ScienceOn
29 Taketani K, Kawauchi J, Tanaka-Okamoto M (2012). Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells. Oncogene, 31, 2210-21.   DOI   ScienceOn
30 Tamura K, Hua B, Adachi S et al. (2005). Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J, 24, 2590-601.   DOI   ScienceOn
31 Tsujino H, Kondo E, Fukuoka T, et al (2000). Activating transcription factor 3 (ATF3). induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci, 15, 170-82.   DOI   ScienceOn
32 Wang H, Jiang M, Cui H, et al (2012). The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor. Mol Cell Biol, 32, 3190-202.   DOI
33 Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ, Hai T (1997). gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol Cell Biol, 17, 6700-7.   DOI
34 Wolfgang CD, Liang G, Okamoto Y, Allen AE, Hai T (2000). Transcriptional autorepression of the stress-inducible gene ATF3. J Biol Chem, 275, 16865-70.   DOI   ScienceOn
35 Wu X, Nguyen BC, Dziunycz P, et al (2010). Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature, 465, 368-72.   DOI   ScienceOn
36 Yin X, Dewille JW, Hai T (2008). A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene, 27, 2118-27.   DOI   ScienceOn
37 Yamaue H, Tanimura H, Noguchi K, et al (1992). Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer, 66, 794-9.   DOI   ScienceOn
38 Yan C, Lu D, Hai T, Boyd DD (2005). Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J, 24, 2425-35.   DOI   ScienceOn
39 Yan C, Wang H, Boyd DD (2002). ATF3 represses 72-kDa type IV collagenase (MMP-2). expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem, 277, 10804-12.   DOI   ScienceOn
40 Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809.   DOI   ScienceOn
41 Zhang C, Kawauchi J, Adachi MT, et al (2001). Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun, 289, 718-24.   DOI   ScienceOn